(RMBS) Rambus - Overview
Sector: TechnologyIndustry: Semiconductors | Exchange NASDAQ (USA) | Currency USD | Market Cap: 10.025m | Total Return 62.8% in 12m
Stock: Memory Chips, Silicon IP, Patents
Total Rating 62
Risk 93
Buy Signal -0.28
| Risk 5d forecast | |
|---|---|
| Volatility | 59.1% |
| Relative Tail Risk | -13.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.99 |
| Alpha | 30.14 |
| Character TTM | |
|---|---|
| Beta | 2.489 |
| Beta Downside | 2.294 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.83% |
| CAGR/Max DD | 0.54 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
volatile
Description: RMBS Rambus March 04, 2026
Rambus Inc. designs and sells semiconductor products globally. The companys primary offerings include memory interface chips, such as DDR5 and DDR4, which are critical components in computing systems for data transfer efficiency. These chips are essential for high-performance computing, including data centers and AI applications.
Rambus also provides silicon IP (Intellectual Property) for interface and security solutions. This includes IP for high-speed memory and chip-to-chip communication, as well as security IP like crypto cores and hardware roots of trust. The semiconductor industry relies heavily on IP licensing for specialized component design.
Additionally, Rambus holds a patent portfolio covering memory architecture, high-speed serial links, and security products. The company sells its products to memory module manufacturers, original equipment manufacturers (OEMs), hyperscalers, and chip makers, utilizing both direct sales and distributors.
To deepen your understanding of Rambuss financials and market position, consider exploring its detailed performance data on ValueRay.
Headlines to watch out for
- DDR5 memory chip demand drives revenue growth
- Semiconductor IP licensing generates recurring income
- Data center and AI adoption increases interface chip sales
- Patent portfolio strength impacts licensing revenue
- Global semiconductor supply chain disruptions affect production
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 230.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.22 > 0.02 and ΔFCF/TA 6.90 > 1.0 |
| NWC/Revenue: 122.7% < 20% (prev 109.3%; Δ 13.39% < -1%) |
| CFO/TA 0.24 > 3% & CFO 360.0m > Net Income 230.5m |
| Net Debt (-139.2m) to EBITDA (314.1m): -0.44 < 3 |
| Current Ratio: 8.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (109.7m) vs 12m ago 0.63% < -2% |
| Gross Margin: 75.97% > 18% (prev 0.75%; Δ 7.52k% > 0.5%) |
| Asset Turnover: 49.27% > 50% (prev 41.44%; Δ 7.82% > 0%) |
| Interest Coverage Ratio: 149.9 > 6 (EBITDA TTM 314.1m / Interest Expense TTM 1.37m) |
Altman Z'' 10.00
| A: 0.57 (Total Current Assets 988.8m - Total Current Liabilities 120.6m) / Total Assets 1.53b |
| B: 0.05 (Retained Earnings 76.8m / Total Assets 1.53b) |
| C: 0.14 (EBIT TTM 205.8m / Avg Total Assets 1.44b) |
| D: 8.73 (Book Value of Equity 1.44b / Total Liabilities 165.1m) |
| Altman-Z'' Score: 14.02 = AAA |
Beneish M -3.24
| DSRI: 0.87 (Receivables 162.7m/147.9m, Revenue 707.6m/556.6m) |
| GMI: 0.99 (GM 75.97% / 75.44%) |
| AQI: 0.65 (AQ_t 0.27 / AQ_t-1 0.41) |
| SGI: 1.27 (Revenue 707.6m / 556.6m) |
| TATA: -0.08 (NI 230.5m - CFO 360.0m) / TA 1.53b) |
| Beneish M-Score: -3.24 (Cap -4..+1) = AA |
What is the price of RMBS shares?
As of March 26, 2026, the stock is trading at USD 95.93 with a total of 2,085,500 shares traded.
Over the past week, the price has changed by +2.80%, over one month by -5.10%, over three months by +1.93% and over the past year by +62.76%.
Over the past week, the price has changed by +2.80%, over one month by -5.10%, over three months by +1.93% and over the past year by +62.76%.
Is RMBS a buy, sell or hold?
Rambus has received a consensus analysts rating of 4.75.
Therefore, it is recommended to buy RMBS.
- StrongBuy: 7
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RMBS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 118.9 | 23.9% |
| Analysts Target Price | 118.9 | 23.9% |
RMBS Fundamental Data Overview March 26, 2026
P/E Trailing = 43.9289
P/E Forward = 24.1546
P/S = 14.1674
P/B = 7.2715
P/EG = 3.8007
Revenue TTM = 707.6m USD
EBIT TTM = 205.8m USD
EBITDA TTM = 314.1m USD
Long Term Debt = 25.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 6.31m USD (from shortTermDebt, last quarter)
Debt = 43.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -139.2m USD (from netDebt column, last quarter)
Enterprise Value = 9.31b USD (10.03b + Debt 43.7m - CCE 761.8m)
Interest Coverage Ratio = 149.9 (Ebit TTM 205.8m / Interest Expense TTM 1.37m)
EV/FCF = 27.93x (Enterprise Value 9.31b / FCF TTM 333.2m)
FCF Yield = 3.58% (FCF TTM 333.2m / Enterprise Value 9.31b)
FCF Margin = 47.08% (FCF TTM 333.2m / Revenue TTM 707.6m)
Net Margin = 32.57% (Net Income TTM 230.5m / Revenue TTM 707.6m)
Gross Margin = 75.97% ((Revenue TTM 707.6m - Cost of Revenue TTM 170.1m) / Revenue TTM)
Gross Margin QoQ = 78.86% (prev 74.43%)
Tobins Q-Ratio = 6.08 (Enterprise Value 9.31b / Total Assets 1.53b)
Interest Expense / Debt = 0.73% (Interest Expense 320k / Debt 43.7m)
Taxrate = 17.31% (13.4m / 77.2m)
NOPAT = 170.2m (EBIT 205.8m * (1 - 17.31%))
Current Ratio = 8.20 (Total Current Assets 988.8m / Total Current Liabilities 120.6m)
Debt / Equity = 0.03 (Debt 43.7m / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = -0.44 (Net Debt -139.2m / EBITDA 314.1m)
Debt / FCF = -0.42 (Net Debt -139.2m / FCF TTM 333.2m)
Total Stockholder Equity = 1.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.04% (Net Income 230.5m / Total Assets 1.53b)
RoE = 18.29% (Net Income TTM 230.5m / Total Stockholder Equity 1.26b)
RoCE = 16.01% (EBIT 205.8m / Capital Employed (Equity 1.26b + L.T.Debt 25.0m))
RoIC = 13.50% (NOPAT 170.2m / Invested Capital 1.26b)
WACC = 14.68% (E(10.03b)/V(10.07b) * Re(14.74%) + D(43.7m)/V(10.07b) * Rd(0.73%) * (1-Tc(0.17)))
Discount Rate = 14.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.16%
[DCF] Terminal Value 59.53% ; FCFF base≈279.9m ; Y1≈303.1m ; Y5≈377.0m
[DCF] Fair Price = 27.32 (EV 2.82b - Net Debt -139.2m = Equity 2.96b / Shares 108.2m; r=14.68% [WACC]; 5y FCF grow 9.38% → 3.0% )
EPS Correlation: 53.60 | EPS CAGR: 133.5% | SUE: 0.0 | # QB: 0
Revenue Correlation: 90.78 | Revenue CAGR: 19.01% | SUE: 0.41 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.59 | Chg7d=+0.007 | Chg30d=+0.011 | Revisions Net=+1 | Analysts=6
EPS current Year (2026-12-31): EPS=2.47 | Chg7d=-0.003 | Chg30d=+0.018 | Revisions Net=+1 | Growth EPS=+17.1% | Growth Revenue=+14.3%
EPS next Year (2027-12-31): EPS=3.06 | Chg7d=-0.082 | Chg30d=-0.092 | Revisions Net=+0 | Growth EPS=+23.7% | Growth Revenue=+16.0%
[Analyst] Revisions Ratio: +0.20 (3 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 12.5% (Discount Rate 14.7% - Earnings Yield 2.3%)
[Growth] Growth Spread = +1.9% (Analyst 14.3% - Implied 12.5%)
P/E Forward = 24.1546
P/S = 14.1674
P/B = 7.2715
P/EG = 3.8007
Revenue TTM = 707.6m USD
EBIT TTM = 205.8m USD
EBITDA TTM = 314.1m USD
Long Term Debt = 25.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 6.31m USD (from shortTermDebt, last quarter)
Debt = 43.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -139.2m USD (from netDebt column, last quarter)
Enterprise Value = 9.31b USD (10.03b + Debt 43.7m - CCE 761.8m)
Interest Coverage Ratio = 149.9 (Ebit TTM 205.8m / Interest Expense TTM 1.37m)
EV/FCF = 27.93x (Enterprise Value 9.31b / FCF TTM 333.2m)
FCF Yield = 3.58% (FCF TTM 333.2m / Enterprise Value 9.31b)
FCF Margin = 47.08% (FCF TTM 333.2m / Revenue TTM 707.6m)
Net Margin = 32.57% (Net Income TTM 230.5m / Revenue TTM 707.6m)
Gross Margin = 75.97% ((Revenue TTM 707.6m - Cost of Revenue TTM 170.1m) / Revenue TTM)
Gross Margin QoQ = 78.86% (prev 74.43%)
Tobins Q-Ratio = 6.08 (Enterprise Value 9.31b / Total Assets 1.53b)
Interest Expense / Debt = 0.73% (Interest Expense 320k / Debt 43.7m)
Taxrate = 17.31% (13.4m / 77.2m)
NOPAT = 170.2m (EBIT 205.8m * (1 - 17.31%))
Current Ratio = 8.20 (Total Current Assets 988.8m / Total Current Liabilities 120.6m)
Debt / Equity = 0.03 (Debt 43.7m / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = -0.44 (Net Debt -139.2m / EBITDA 314.1m)
Debt / FCF = -0.42 (Net Debt -139.2m / FCF TTM 333.2m)
Total Stockholder Equity = 1.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.04% (Net Income 230.5m / Total Assets 1.53b)
RoE = 18.29% (Net Income TTM 230.5m / Total Stockholder Equity 1.26b)
RoCE = 16.01% (EBIT 205.8m / Capital Employed (Equity 1.26b + L.T.Debt 25.0m))
RoIC = 13.50% (NOPAT 170.2m / Invested Capital 1.26b)
WACC = 14.68% (E(10.03b)/V(10.07b) * Re(14.74%) + D(43.7m)/V(10.07b) * Rd(0.73%) * (1-Tc(0.17)))
Discount Rate = 14.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.16%
[DCF] Terminal Value 59.53% ; FCFF base≈279.9m ; Y1≈303.1m ; Y5≈377.0m
[DCF] Fair Price = 27.32 (EV 2.82b - Net Debt -139.2m = Equity 2.96b / Shares 108.2m; r=14.68% [WACC]; 5y FCF grow 9.38% → 3.0% )
EPS Correlation: 53.60 | EPS CAGR: 133.5% | SUE: 0.0 | # QB: 0
Revenue Correlation: 90.78 | Revenue CAGR: 19.01% | SUE: 0.41 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.59 | Chg7d=+0.007 | Chg30d=+0.011 | Revisions Net=+1 | Analysts=6
EPS current Year (2026-12-31): EPS=2.47 | Chg7d=-0.003 | Chg30d=+0.018 | Revisions Net=+1 | Growth EPS=+17.1% | Growth Revenue=+14.3%
EPS next Year (2027-12-31): EPS=3.06 | Chg7d=-0.082 | Chg30d=-0.092 | Revisions Net=+0 | Growth EPS=+23.7% | Growth Revenue=+16.0%
[Analyst] Revisions Ratio: +0.20 (3 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 12.5% (Discount Rate 14.7% - Earnings Yield 2.3%)
[Growth] Growth Spread = +1.9% (Analyst 14.3% - Implied 12.5%)